Inhibition of Proinflammatory Cytokines by SCH79797, a Selective Protease-Activated Receptor 1 Antagonist, Protects Rat Kidney Against Ischemia-Reperfusion Injury
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Critical Care and Intensive Care Medicine,Emergency Medicine
Reference33 articles.
1. Pathophysiology of ischemic acute kidney injury.;Sharfuddin;Nat Rev Nephrol,2011
2. Neutrophils and renal failure.;Heinzelmann;Am J Kidney Dis,1999
3. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.;Butcher;Cell,1991
4. Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure.;Singbartl;FASEB J,2001
5. Pretreatment with the tumor necrosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury.;Choi;Transplant Proc,2009
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characterizing Modulators of Protease-activated Receptors with a Calcium Mobilization Assay Using a Plate Reader;Journal of Visualized Experiments;2024-05-24
2. Vorapaxar proven to be a promising candidate for pulmonary fibrosis by intervening in the PAR1/JAK2/STAT1/3 signaling pathway-an experimental in vitro and vivo study;European Journal of Pharmacology;2023-03
3. PAR1, a therapeutic target for remote lung injury associated with hind limb ischemia/reperfusion: ERK5/KLF2-dependent lung capillary barrier preservation;Chemico-Biological Interactions;2022-02
4. Vorapaxar Prove to Be a Promising Candidate for Pulmonary Fibrosis by Intervening Thrombin/PAR1/JAK/STAT Signaling Pathway;SSRN Electronic Journal;2022
5. Protease-Activated Receptor-1 Antagonist Protects Against Lung Ischemia/Reperfusion Injury;Frontiers in Pharmacology;2021-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3